MKP Capital Management L.L.C. Makes New $16.39 Million Investment in The Cooper Companies, Inc. $COO

MKP Capital Management L.L.C. bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 200,000 shares of the medical device company’s stock, valued at approximately $16,392,000. Cooper Companies makes up 0.6% of MKP Capital Management L.L.C.’s portfolio, making the stock its 19th largest position. MKP Capital Management L.L.C. owned about 0.10% of Cooper Companies as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. New Mexico Educational Retirement Board grew its holdings in Cooper Companies by 3.3% during the 4th quarter. New Mexico Educational Retirement Board now owns 9,300 shares of the medical device company’s stock worth $762,000 after acquiring an additional 300 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in Cooper Companies by 1.6% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 65,818 shares of the medical device company’s stock worth $5,394,000 after acquiring an additional 1,040 shares in the last quarter. MUFG Securities EMEA plc grew its holdings in Cooper Companies by 114.4% during the 4th quarter. MUFG Securities EMEA plc now owns 8,188 shares of the medical device company’s stock worth $671,000 after acquiring an additional 4,369 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in Cooper Companies by 2.5% during the 4th quarter. BNP Paribas Financial Markets now owns 262,305 shares of the medical device company’s stock worth $21,499,000 after acquiring an additional 6,427 shares in the last quarter. Finally, Forsta AP Fonden grew its holdings in Cooper Companies by 5.5% during the 4th quarter. Forsta AP Fonden now owns 42,000 shares of the medical device company’s stock worth $3,442,000 after acquiring an additional 2,200 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of several recent research reports. Needham & Company LLC increased their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Citigroup reissued a “neutral” rating and set a $69.00 price target (down from $80.00) on shares of Cooper Companies in a research report on Thursday. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday. Finally, The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $88.07.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $60.19 on Tuesday. The firm has a market capitalization of $11.74 billion, a P/E ratio of 29.80, a PEG ratio of 1.58 and a beta of 0.88. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a 50 day moving average price of $65.75 and a 200 day moving average price of $74.81. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.